Clovis Oncology, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$388.6M

1,657 transactions

Summary

Clovis Oncology, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $298.5MSales: $50.0M45 insiders

Date	Insider	Type	Value
2022-11-02	Gross Paul Edward(See Remarks)	Sell	$3K
2022-11-02	MUEHL DANIEL W(See Remarks)	Sell	$2K
2022-11-02	Rolfe Lindsey(See Remarks)	Sell	$2K
2022-11-02	Gross Paul Edward(See Remarks)	Sell	$2K
2022-11-02	MUEHL DANIEL W(See Remarks)	Sell	$2K
2022-11-02	IVERS-READ GILLIAN C(See Remarks)	Sell	$2K
2022-11-02	Rolfe Lindsey(See Remarks)	Sell	$2K
2022-11-02	IVERS-READ GILLIAN C(See Remarks)	Sell	$2K
2022-11-02	Harding Thomas C.(See Remarks)	Sell	$896.7
2022-11-02	Harding Thomas C.(See Remarks)	Sell	$772.24
2022-11-02	Harding Thomas C.(See Remarks)	Sell	$61.74
2022-11-01	Rolfe Lindsey(See Remarks)	M	$0
2022-11-01	Rolfe Lindsey(See Remarks)	M	$0
2022-11-01	Rolfe Lindsey(See Remarks)	M	—
2022-11-01	Rolfe Lindsey(See Remarks)	M	—
2022-11-01	MUEHL DANIEL W(See Remarks)	M	$0
2022-11-01	MUEHL DANIEL W(See Remarks)	M	$0
2022-11-01	MUEHL DANIEL W(See Remarks)	M	—
2022-11-01	MUEHL DANIEL W(See Remarks)	M	—
2022-11-01	Harding Thomas C.(See Remarks)	M	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Clovis Oncology, Inc. — Contributions, Lobbying & Contracts | Poliscope